Intrainfusion and postinfusion adverse events related to intravenous immunoglobulin therapy in immunodeficiency states

By Tcheurekdjian Haig   Martin Jamila   Kobayashi Roger   Wasserman Richard   Hostoffer Robert  

Allergy and Asthma Proceedings, Vol. 27, Iss. 6, 2006-11 ,pp. : 532-536

OceanSide Publications, Inc

Access to resources Recommend Favorite

Patient Safety Culture and Nurse-Reported Adverse Events in Outpatient Hemodialysis Units

By Thomas-HawkinsCharlotteSchool of Nursing   Rutgers University   Newark   New Jersey   USA   FlynnLinda  

Scholarly Inquiry for Nursing Practice, Vol. 29, Iss. 1, 2015-02 ,pp. : 53-65

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency - A randomized double-blind trial

By Roifman C.M.   Schroeder H.   Berger M.   Sorensen R.   Ballow M.   Buckley R.H.   Gewurz A.   Korenblat P.   Sussman G.   Lemm G.   the IGIV-C in PID Study Group  

International Immunopharmacology, Vol. 3, Iss. 9, 2003-09 ,pp. : 1325-1333

Elsevier

Access to resources Recommend Favorite

Cognitive Aspects of Adverse Events

By Redman Richard W.  

Scholarly Inquiry for Nursing Practice, Vol. 21, Iss. 1, 2007-03 ,pp. : 10-12

Springer Publishing Company

Access to resources Recommend Favorite

Medication Station: Reducing Anticoagulation-Related Adverse Drug Events: Closely monitoring and managing risks for patients on warfarin

By  

Joint Commission Perspectives on Patient Safety, Vol. 6, Iss. 7, 2006-07 ,pp. : 3-4

Joint Commission Resources

Access to resources Recommend Favorite